About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company's Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company's Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. Bio-Rad sells over 8,000 products and services to a client base consisting of scientific research, healthcare, education and government customers around the world.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Laboratories & Research
- Sub-Industry: Life Sciences Tools & Services
- Exchange: NYSE
- Symbol: BIO
- CUSIP: 09057220
- Previous Close: $191.85
- 50 Day Moving Average: $187.19
- 200 Day Moving Average: $168.46
- 52-Week Range: $29,541,000.00 - $123.68
- Trailing P/E Ratio: 58.14
- Foreward P/E Ratio: 64.86
- P/E Growth: -17.66
- Market Cap: $5.71B
- Outstanding Shares: 29,541,000
- Beta: 0.89
- Net Margins: 4.75%
- Return on Equity: 3.79%
- Return on Assets: 2.56%
Companies Related to Bio-Rad Laboratories:
- Debt-to-Equity Ratio: 0.16%
- Current Ratio: 4.18%
- Quick Ratio: 2.92%
What is Bio-Rad Laboratories' stock symbol?
Bio-Rad Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "BIO."
Where is Bio-Rad Laboratories' stock going? Where will Bio-Rad Laboratories' stock price be in 2017?
3 analysts have issued twelve-month price targets for Bio-Rad Laboratories' stock. Their predictions range from $180.00 to $225.00. On average, they anticipate Bio-Rad Laboratories' share price to reach $200.00 in the next twelve months.
When will Bio-Rad Laboratories announce their earnings?
Bio-Rad Laboratories is scheduled to release their next quarterly earnings announcement on Thursday, February, 23rd 2017.
Who owns Bio-Rad Laboratories stock?
Bio-Rad Laboratories' stock is owned by many different of institutional and retail investors. Top institutional investors include Atlanta Capital Management Co. L L C (6.04%), State Street Corp (1.82%), NWQ Investment Management Company LLC (1.37%), Levin Capital Strategies L.P. (0.91%), Thompson Siegel & Walmsley LLC (0.71%) and Russell Investments Group Ltd. (0.68%).
Who sold Bio-Rad Laboratories stock? Who is selling Bio-Rad Laboratories stock?
Bio-Rad Laboratories' stock was sold by a variety of institutional investors in the last quarter, including Levin Capital Strategies L.P., Martingale Asset Management L P, NWQ Investment Management Company LLC, Thompson Siegel & Walmsley LLC, Highland Capital Management LP, Atlanta Capital Management Co. L L C, AQR Capital Management LLC and Guggenheim Capital LLC.
Who bought Bio-Rad Laboratories stock? Who is buying Bio-Rad Laboratories stock?
Bio-Rad Laboratories' stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., FMR LLC, Tudor Investment Corp Et Al, Perceptive Advisors LLC, Lodge Hill Capital LLC, Employees Retirement System of Texas, Teachers Retirement System of The State of Kentucky and Folger Hill Asset Management LP.
How do I buy Bio-Rad Laboratories stock?
Shares of Bio-Rad Laboratories can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Bio-Rad Laboratories stock cost?
One share of Bio-Rad Laboratories stock can currently be purchased for approximately $193.27.